Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CD14 |
| Upstream (Parents) |
|---|
| (<<) APOE → CD14 |
| (<<) KMO → CD14 |
| (<<) A2M → CD14 |
| (<<) DPYD → CD14 |
| Downstream (Children) |
|---|
| CD14 → TSPAN4 (>>) |
| CD14 → CPVL (>>) |
| CD14 → ATP8B4 (>>) |
| CD14 → APBB1IP (>>) |
| CD14 → INPP5J (>>) |
| CD14 → SELE (>>) |
| CD14 → MARCO (>>) |
| CD14 → PLAC1 (>>) |
| CD14 → APOE (>>) |
| CD14 → P2RY13 (>>) |
| CD14 → LILRB5 (>>) |
| CD14 → ABHD8 (>>) |
| CD14 → A2M (>>) |
| CD14 → DPYD (>>) |
| CD14 → EMR1 (>>) |
| CD14 → TMEM140 (>>) |
| CD14 → CR1 (>>) |
| CD14 → CPM (>>) |
| CD14 → CTSL1 (>>) |
| CD14 → PLCG2 (>>) |
| CD14 → MAFB (>>) |
| CD14 → MS4A6A (>>) |
| CD14 → IFIT2 (>>) |
